Patent · US Active

Disease characterization and response estimation through spatially-invoked radiomics and deep learning fusion

US11810292B2 · kind B2 · utility

1Cited by
0References
32Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 30, 2020
Grant dateNov 7, 2023
Priority date
Expiry dateSep 9, 2041

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG06V2201/03
  • WIPO fieldComputer technology
  • WIPO sectorElectrical engineering

Abstract

Embodiments discussed herein facilitate training and/or employing a combined model employing machine learning and deep learning outputs to generate prognoses for treatment of tumors. One example embodiment can extract radiomic features from a tumor and a peri-tumoral region; provide the intra-tumoral and peri-tumoral features to two separate machine learning models; provide the segmented tumor and peri-tumoral region to two separate deep learning models; receive predicted prognoses from each of the machine learning models and each of the deep learning models; provide the predicted prognoses to a combined machine learning model; and receive a combined predicted prognosis for the tumor from the combined machine learning model.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.